Aromatase is a cytochrome P-450 enzyme complex that catalyzes the conversion of androst-4-ene-3,17-dione (AD) to estrone through three sequential oxygenations of the 19-methyl group. To gain insight into the ability of AD isomers, 4-en-6-one 1a, 5-en-4-one 2a, and 5-en-7-one 3a, competitive inhibitors of aromatase with an A, Bring enone structure to serve as a substrate, we incubated the three inhibitors separately with human placental aromatase in the presence of NADPH in air. The metabolites were analyzed as the methoxime-trimethylsilyl ethers by gas chromatography-mass spectrometry. All of the inhibitors were found to be oxygenated with aromatase to produce the corresponding 19-hydroxy derivatives 1b, 2b, and 3b with rates of 2.0, 51, and 0.3 pmol/ min/mg protein, respectively. Only in the experiment with the 5-en-4-one steroid 2a, the production of the 19-oxo metabolite 2c was detected with a rate of 3.1 pmol/min/mg protein. The 19-oxygenation of steroid 2a, the best substrate for aromatase among the three, was kinetically determined to give the V max value of 40 pmol/min/mg protein and the K m value of 1.43 m mM, respectively. The results reveal that a good inhibitor of aromatase is not essentially a good substrate for the enzyme in a series of the A, B-ring enone steroids.
Aromatase is a unique cytochrome P-450 enzyme complex responsible for estrogen biosynthesis in vivo. [1] [2] [3] The aromatase reaction is thought to proceed through three sequential oxygenations at C-19 of the androgens androstenedione (AD) and testosterone. The first two occur at the C-19 position to produce 19-hydroxy and 19-oxo intermediates. In the last step, C-19 and the 1b,2b-protons are eliminated as formic acid and water, respectively (Fig. 1) . [4] [5] [6] [7] Inhibitors of aromatase are valuable as therapeutic agents in the treatment of breast cancer. 8) For this reason, a number of potent aromatase inhibitors, which are analogs of the substrate AD, have been described by various laboratories.
We previously reported that C 19 -steroids, having a unique enone structure in a A, B-ring system, such as 4-en-6-one 1a, 9) 5-en-4-one 2a, 10) and 5-en-7-one 3a, 11) instead of the 4-en-3-one structure of AD, efficiently inhibit aromatase activity in a competitive manner, even though there is no oxygen function at the C-3 position (Fig. 2) . Steroid 1a has the highest affinity for aromatase among the four enones including the substrate AD 9) whereas the 5-en-7-one 3a, with the lowest affinity, inactivates aromatase in a suicide manner. 12) Moreover, it was also reported that 3-deoxy AD as well as its 5-ene isomer, both good inhibitors of aromatase, can serve as a substrate of the enzyme that results in the formation of 19-oxygenated products in each. 13) In connection with work in our laboratory on the ability of aromatase inhibitors to serve as a substrate, it was of interest to determine whether aromatase can catalyze the 19-oxygenation of the 3-deoxy-enone steroids 1a, 2a, and 3a. This paper describes the identification of 19-oxygenated metabolites formed from the enones 1a, 2a, and 3a with human placental aromatase, as well as the kinetic study of the 19-oxygenation, using gas chromatography-mass spectrometry (GC-MS). All of the enones were oxygenated at C-19 with aromatase, the 5-en-4-one compound 2a was the best substrate for the enzyme.
MATERIALS AND METHODS

Materials
The a,b-unsaturated ketones 1a, 9) 2a, 10) and 3a, 11) their 19-hydroxy-(1b, 2b, and 3b) and 19-oxo-(1c, 2c, and 3c) analogs, 12, [14] [15] [16] and androst-5-ene-17b,19-diol 14) Fig 17) and they were washed with 0.05 mM dithiothreitol solution, lyophilized, and stored at Ϫ20°C.
19-Oxygenation Studies with GC-MS
Incubations were conducted in a shaking water bath at 37°C in air with 30 ml Erlenmeyer flasks. Each contained 4.7 mM of steroids 1a, 2a, and 3a, 114 mM NADPH, 500 mg of protein of placental microsomes, 100 ml of methanol and 67 mM phosphate buffer, pH 7.4, with a total volume of 2.1 ml. For each experiment, four parallel incubations were performed. After 30 min of incubation, androst-5-ene-17b,19-diol (100 ng) as an internal standard was added to each incubation mixture. The metabolites as well as the internal standard were extracted twice with 5 ml of ethyl acetate. The organic layer was evaporated under reduced pressure to give a residue, which was dissolved in 100 ml of methanol, diluted with water (3 ml), and placed in a Sep-Pak C 18 cartridge (Waters, Milford, MA, U.S.A.). After a wash with water (5 ml) followed by 10% methanol (5 ml), the steroid fraction was eluted with 80% methanol (10 ml). For the kinetic analysis, the incubation mixture contained 0.50, 1.0, 2.5, or 5.0 mM concentration of the 5-en-4-one steroid 2a, 100 mg of the microsomal protein and 57.1 mM NADPH, 100 ml of methanol, and the 67 mM phosphate buffer, pH 7.4, in a 30 ml Erlenmeyer flask with a total volume 1.0 ml. The mixture was incubated separately for 5 min in air, and then the 17b,19-diol steroid (25 ng) as an internal standard was added to each incubation mixture, and the steroidal material was extracted twice with 5 ml of ethyl acetate. The organic layer was evaporated to give a residue which was dissolved in methanol (100 ml), and diluted with water (3 ml) and then placed in a Sep-Pak C 18 cartridge. After the same work-up as described above, the steroid fraction was obtained. The recovery rates for the 19-ols 1b, 2b, and 3b and the 19-oxo analogs 2c, as well as the internal standard, were about 65-70%.
Derivatization of the 19-Oxygenated Products The 19-oxygenated products obtained by the solid-phase extraction with a Sep-Pak C 18 cartridge were dissolved in pyridine (50 ml) containing 5% methoxyamine hydrochloride, and the mixture was heated at 60°C for 30 min. After this time, the mixture was diluted with ethyl acetate (6 ml), washed with water (2 ml), and evaporated to dryness under a stream of N 2 to yield a residue; in this reaction, the carbonyl compound was converted into the methoxime (MO) derivative. The residue was further treated with BSTFA according to the method previously reported 13) ; in this treatment, the trimethylsilyl (TMS) derivative was produced from the hydroxy compound. Additionally, DMIPS-imidazole (20 ml) was added to the mixture containing the MO derivative obtained as above and then the resulting mixture was further heated at 60°C for 30 min, then placed in a Sephadex LH-20 column (5.0 cmϫ0.6 cm i.d.; Pharmacia, Uppsala, Sweden). The column was developed with 2.5 ml of CHCl 3 /hexane/ methanol (10/10/1, v/v) and evaporation of the solvent gave a residue containing the DMIPS derivatives. This was dissolved in hexane (25 ml) containing 0.5% pyridine and subjected to the GC-MS analysis. Kinetic Study The 19-hydroxy product 2b obtained from the incubation of the 5-en-4-one steroid 2a, was converted into the MO-TMS derivative and was injected into GC-MS as described above to obtain the aromatase-catalyzing 19-oxygenation rate of the steroid 2a.
GC-MS Instruments used were Finnigan MAT SSQ GC-MS (San Jose, CA, U.S.A.) and a HP 5970B GC-MS (Palo Alto, CA, U.S.A.). GC and MS (electron impact, EI-MS) conditions were essentially similar to those previously reported.
18) The quantitative analysis of MO-TMS derivatives of the 19-ols 1b, 2b, and 3b, as well as the tris-MO derivative of the 19-oxo steroid 2c, was conducted with a selected ion monitoring method with a base peak ion, in each case. Aromatization Assay The aromatization rate of AD was determined by measuring the amount of tritiated water released from [1b- 3 H]AD, a substrate for aromatase, into the incubation medium during aromatization, according to the method previously reported. 19) RESULTS AND DISCUSSION 19-Oxygenation studies of the A, B-ring enone steroids 1a, 2a, and 3a were initially carried out to determine whether they are converted into the corresponding 19-hydroxyand/or 19-oxo-compounds by human placental aromatase in the presence of NADPH under an aerobic condition. The incubation products were subjected to reaction with methoxyamine followed by silylation with BSTFA or DMIPSimidazole, and then analyzed using GC-MS. Mass spectra and retention times of the derivatives, the MO-TMS and MO-DMIPS derivatives of the 19-hydroxy steroids 1b, 2b, and 3b, and the tris-MO derivatives of the 19-oxo-5-en-4-one 2c were identical with those of the corresponding authentic samples, respectively (Figs. 3 and 4) . In contrast, in the incubation experiments using the 4-en-6-one 1a and the 5-en-7-one 3a, any production of their 19-oxo metabolites 1c and 3c was not detected under the assay conditions employed, respectively (lower detection limit : about 100 pg for 1c and 3c). The results revealed that the 3-deoxy-enones 1a, 2a, and 3a, good aromatase inhibitors, were oxygenated at their 19-methyl group by human placental microsomes, yielding their 19-hydroxy metabolites 1b, 2b, and 3b. In addition, the 5-en-4-one steroid 2a was converted into the 19-oxo compound 2c through two sequential oxygenations at the 19-methyl, as seen in the aromatization sequence of the substrate AD [4] [5] [6] [7] as well as the aromatase reaction of 3-deoxy AD and its 5-ene isomer. 13) However, the production of the 17b-hydroxy derivatives of the 19-ols was not observed by the GC-MS analysis in each incubation experiment, suggesting that these enones would be poor substrates for 17b-hydroxysteroid dehydrogenase.
On the basis of relative total ion volumes in the GC-MS spectra of the 19-hydroxy metabolites to that of the internal standard, it was indicated that the 5-en-4-one substrate 2a was a proper substrate for the 19-hydroxylation while the other two were poor ones. The production rates of the 19-hydroxy metabolites 1b, 2b, and 3b were then determined using the selected ion monitoring method (EI mode) with a base peak ion, m/z 329 (M ϩ Ϫ103), of the MO-TMS derivatives in each case (Table 1 ). The 19-hydroxylation rates of steroids 1a and 2a at a concentration of 4.7 mM increased linearly with increasing amounts of placental microsomes (up to 600 mg of protein for 2a and 1000 mg of protein for 1a) and with incubation time (up to 60 min in each). The 19-hydroxylations of steroids 1a and 2a along with the formation of the 19-oxo metabolite 2c were significantly prevented by AD (5.0 mM), the natural substrate of aromatase. These results indicate that the 19-oxygenations are catalyzed by aromatase in placental microsomes.
The 19-hydroxylation of steroid 2a was further studied to characterize the affinity (K m ) for aromatase and the conversion rate (V max ) under initial velocity conditions in which the conversion of the substrate 2a to the 19-ol 2b was less than 5% in each case. This 19-hydroxylation showed a typical saturation curve with an increasing substrate concentration (Fig.  5) , and the Lineweaver-Burk plot gave apparent K m and V max values of 1.43 mM and 40 pmol/min/mg protein, respectively. In this study, the apparent K m and V max values for the natural substrate AD, which were obtained by a radiometric assay with [1b-3 H]AD as a substrate, were 33 nM and 120 pmol/ min/mg protein, respectively. The apparent K m value for steroid 2a was much higher compared to that for the AD aromatization and about twelve times higher than its own inhibition constant (K i : 120 nM) obtained in the previous study.
10) The fact that the V max value for steroid 2a was 33% of that for the AD aromatization, indicates that this steroid was a good substrate for aromatase, although there is no 4-en-3-one structure in the A, B-ring system. The 4-en-6-one steroid 1a, the most potent competitive inhibitor of aromatase (K i : 21 nM) 9) among the three enones, was a poor substrate, of which the 19-hydroxylation rate was less than 5% of the isomer 2a.
Thus, there is no significant correlation between the ability to serve as an inhibitor of aromatase and the ability to serve as a substrate of the enzyme in series of the A, B-ring enone steroids, as seen in the 6-alkyl 18, 20) and 3-deoxy 13) androgen series. The 5-en-4-one steroid 2a would bind to the active site in geometry similar to that involved in the binding of the natural substrate AD, in which the 19-methyl group orients in a proper position for the cause of the catalytic function of aromatase. In contrast, the binding geometry of the other two enones, of which the 5-en-7-one 3a is a suicide substrate for aromatase, would be obviously different from that of AD and be less suitable for the 19-oxygenation. The reason for these structural features observed in the aromatase-catalyzed 19-oxygenation of the enones is currently unknown. We previously suggested that the suicide substrate 3a might inactivate the enzyme in a mechanism-based manner through the 19-oxygenation.
12) The fact that the inactivator 3a is oxygenated at C-19 by aromatase, although the oxygenation rate is not very high, would support the involvement of the 19-oxygenation mechanism for the inactivation by compound 3a. 4 .0Ϯ0.30 ND 5-En-7-one 3a 0.3Ϯ0.04 ND a) All steroids (4.7 mM) were incubated separately with human placental microsomes (500 mg of protein) at 37°C for 30 min in the presence of NADPH (114 mM) in 2.1 ml of 67 mM phosphate buffer, pH 7.4. The 19-hydroxy and 19-oxo products were analyzed as the MO-TMS and MO derivative, respectively, with an internal standard as described in the Experimental. Results are meanϮS.D. (nϭ4). b) ND: not detected. The detection limit of the 19-oxo steroids. 1c, 2c, and 3c was about 0.5 pmol/min/mg protein in each. c) AD (5.0 mM) was added to the incubation mixture and the 19-oxygenated products were analyzed as described above.
